Trial Design Articles

Oct 01, 2014
Proving a biosimilar's pharmacokinetic 'equivalence' requires adherence to several unique factors.
Oct 01, 2014
Research shows that the potential of integrated alliances remains elusive in the near term.
Oct 01, 2014
A systematic approach for early identification of BP effects during development of new drugs.
Oct 01, 2014
How modeling and simulation clarified complex exposure levels and an orphan drug got approved.
Jul 29, 2014
Miniaturization of sensors and circuitry has enabled huge proliferation in the development and commercialization of wearable and external monitoring devices for health and wellness.
Jul 01, 2014
Regulatory authorities routinely inspect clinical trials, sites, sponsors, investigators, and other relevant parties to ensure compliance with good clinical practice guidelines.
Jul 01, 2014
Objective internal monitoring can help clinical trial sponsors transform a regulatory mandate into a valuable quality improvement tool.
Jul 01, 2014
Conducting Large Simple Trials to answer questions about "real-world" medical interventions is not a recent concept.
Jun 26, 2014
PCORI underscored existing trends toward increasingly individualized and personalized medical care...

Trial Design News

PPD and ERT Establish Strategic Partnership

PPD and ERT announced a strategic partnership.

CRF Health Partners with EuroQol for eCOA

CRF Health announced an agreement with EuroQol to launch the EQ-5D web system on its TrialMax Web software platform.

Cancer Treatment Centers of America Selects WIRB-Copernicus Group

WIRB-Copernicus Group announced that it has been chosen by Cancer Treatment Centers of America to expand its clinical research program.

Almac and ESMS Global Collaborate on Emergency Unblinding

Almac and ESMS have combined their expert knowledge to offer clients an exclusive solution surrounding emergency unblinding procedures.

AiCure, NIDA Assess Medication Abuses in Trial

AiCure has announced the start of a major clinical trial to monitor and intervene with patients receiving medication as maintenance therapy for opioid addiction